Photo from racap.com ↗Profile · racap.com ↗

Nandita Shangari

Investor

Latest on AI4S.fyiFunding · Sep 5 · Managing Director; member of the board, RA Capital ManagementSuperluminal Medicines · Series B · $60M

Investment relationships shown here are limited to companies and funding rounds tracked by AI4S.fyi; they are not a complete investor portfolio.

Photos come from each person's X account, their own site, lab or team page, a conference page that lists them as a speaker in the same role, or Wikimedia Commons under the licence credited, so some may be out of date. Anyone can ask for theirs to be replaced or removed. Contact →

Linked funding records

Superluminal MedicinesDrug discovery · Series B · 2026-09-05 · $60M
RA Capital Management Managing Director; member of the board · joined the board · source ↗

On the timeline

2026-09-05Superluminal Medicines, which designs GPCR drugs with machine learning and cryo-EM, raises a $60M Series B led by BVF Partners to take its first drug into the clinic

Something wrong or missing on this page? Tell me and it will be fixed or removed. Contact →